Propionibacterium Acnes in Shoulder Arthroplasty
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03057821 |
Recruitment Status :
Completed
First Posted : February 20, 2017
Last Update Posted : August 30, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Propionibacterium Acnes | Other: 3% hydrogen peroxide | Not Applicable |
Over half of all post-operative infections after shoulder arthroplasty are due to Propionibacterium acnes. Even in apparently "aseptic" revisions, nearly all cultures taken at the time of revision surgery are positive for P acnes, and thus low-grade infection with this bacteria may be a more common cause of failure than previously suspected. Current antibiotic prophylaxis methods are ineffective against P acnes. Despite intravenous cefazolin, P acnes can be cultured from the glenohumeral joint in 42% of patients undergoing primary total shoulder arthroplasty. Despite skin preparation with chlorhexidine, P acnes can be cultured from 73% of portal sites in arthroscopy. P acnes is further insensitive to alcohol. Dermatologists have long been treating P acnes as it is a primary cause of acne vulgaris. One of the most popular and effective treatments for acne vulgaris is topical benzoyl peroxide. A prior prospective clinical trial demonstrated that adding topical 5% benzoyl peroxide 48 hours prior to surgery reduced P acnes culture positivity to 6%. The downside of this treatment is that it must be applied by the patient, at home, for 48 hours prior to surgery. An additional downside is that benzoyl peroxide is a skin irritant that not all patients tolerate.
In aqueous environments, benzoyl peroxide rapidly decomposes into benzoic acid and hydrogen peroxide. Benzoic acid is a skin irritant and hydrogen peroxide is the active ingredient. Benzoyl peroxide is used instead of hydrogen peroxide because hydrogen peroxide breaks down into water and oxygen when exposed to light. Recently, stabilized forms of hydrogen peroxide have been developed and have been demonstrated to be equally effective to benzoyl peroxide in the treatment of acne vulgaris. One potential reason for hydrogen peroxide's efficacy against P acnes is that it is absorbed into the skin, addressing P acnes residing in sebaceous glands. To date, no studies have examined whether the addition of hydrogen peroxide to pre-operative skin preparation can reduce intra-operative P acnes culture positivity.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 62 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Does Hydrogen Peroxide Skin Preparation Reduce Propionibacterium Acnes in Shoulder Arthroplasty? |
Actual Study Start Date : | January 2017 |
Actual Primary Completion Date : | March 2019 |
Actual Study Completion Date : | March 2019 |
Arm | Intervention/treatment |
---|---|
No Intervention: Control
The control group will not receive any hydrogen peroxide skin preparation
|
|
Experimental: Treatment
The treatment group will also undergo skin preparation with 3% hydrogen peroxide.
|
Other: 3% hydrogen peroxide
The treatment group will also undergo skin preparation with 3% hydrogen peroxide. |
- Positive P acnes culture [ Time Frame: 2-weeks ]The primary outcome of the study will be P acnes culture positive results.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years to 90 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients undergoing primary shoulder arthroplasty
Exclusion Criteria:
- Patients with prior shoulder surgery.
- Patients with a symptomatic infection or history of infection, recent antibiotic use (within six weeks), or with clinical signs of infection such as an elevated ESR, CRP, positive aspiration cultures, or positive biopsy.
- Patients with a known hypersensitivity to hydrogen peroxide.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03057821
United States, Utah | |
University of Utah Orthopaedic Center | |
Salt Lake City, Utah, United States, 84108 |
Principal Investigator: | Peter Chalmers, MD | University of Utah |
Responsible Party: | Peter Chalmers, Principle Investigator, University of Utah |
ClinicalTrials.gov Identifier: | NCT03057821 |
Other Study ID Numbers: |
96964 |
First Posted: | February 20, 2017 Key Record Dates |
Last Update Posted: | August 30, 2019 |
Last Verified: | August 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
hydrogen peroxide Propionibacterium Acnes shoulder arthroplasty |
Acne Vulgaris Acneiform Eruptions Skin Diseases Sebaceous Gland Diseases |
Hydrogen Peroxide Anti-Infective Agents, Local Anti-Infective Agents |